Kraig Labs signs long term lease and prepares to plant 2,000 mulberry trees

ANN ARBOR, Mich., -January 24, 2017- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced it had secured a long term property lease in Texas for the Company’s domestic mulberry production. Over the next 60 days the Company will complete the first phase of expansion by preparing the land and planting 2,000 mulberry trees. These trees will provide the Company with the continuous supply of fresh mulberry leaves needed to produce its record setting Dragon Silk^TM. The Company expects to see an improvement in materials performance and a reduction in production costs by as much as 30% through the use of locally sourced mulberry.

“Signing this lease and opening this new facility brings with it a new era for Kraig Labs and silk production in the US,” said COO Jon Rice. “Establishing domestic mulberry production has long been a key piece of our growth plan, today we are pleased to be able share the success of our efforts in bringing that vision into reality. Over the coming months we will complete the planting of the first 2,000 trees and prepare the facility for the next phase of expansion.”

This property offers the Company significant capacity for growth with room for tens of thousands of more trees.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., – January 12, 2017 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that the Company’s management just completed a series of successful meetings with government officials in Vietnam designed to outline a collaborative path to large scale production of the Company’s high performance silk technologies.  Following the meeting with provincial leadership, Company management toured mulberry production, silkworm rearing, and textile weaving facilities in the province of Quang Nam to better assess the region’s capacity. 

“We were very impressed with what we saw in Quang Nam, its people, history, and capacity makes it a great location for our advanced silk production,” said COO Jon Rice.

“We would, again, like to thank the Chairman, Vice Chairman and numerous other leaders of the province for their support and enthusiasm in exploring the opportunity to bring our technology to Quang Nam province,” added Company founder and CEO, Kim Thompson. 

This meeting was also recently reported by officials in Quang Nam province, Vietnam.  http://ipaquangnam.gov.vn/eng/tin-tuc-chi-tiet/lanh-dao-ubnd-tinh-tiep-va-lam-viec-voi-lanh-dao-cong-ty-kraig-biocraft-laboratories-hoa-ky.html

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -December 6, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, was featured in the broadcast television show “Nature Knows Best” aired on November 19th. “Nature Knows Best” is a nationally syndicated STEM series exploring how scientists and engineers mimic nature to create some of the world’s most amazing materials. The segment from episode 11 of this series featuring Kraig Labs can be found on the Company’s YouTube channel at:

https://youtu.be/p68KPyAsiug or;

https://www.kraiglabs.com/videos/

“Nature Knows Best” is produced by Steve Rotfeld Productions and airs on Fox. The first 9 full episodes of “Natures Knows Best” are currently available for streaming on Amazon, Ruko, or Hulu.

“I want to personally thank Danni Washington and the entire ‘Nature Knows Best’ crew for doing such an incredible job of featuring our spider silk technology,” said COO Jon Rice. “We are always looking for ways to share our incredible technology and materials with new audiences. To be included in such a strong episode of this innovative science program, just as we’re preparing to ship out or first production order of Dragon silk cocoons from our Indiana factory, is very exciting.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Laboratories Promising New Line of Silkworm Transgenics Shows Incredible Results

ANN ARBOR, Mich., -October 31, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced it has created a new line of genetically engineered silkworms that rival the Company’s Dragon Silk^TM  for the title as world’s strongest and most flexible recombinant spider silk.   Based on early testing results, this new line has a high probability of delivering performance exceeding that of the record setting Dragon Silk line announced in 2015.  Over the next several months the Company will conduct a thorough evaluation and performance comparison between these two incredible materials.

“This brand new transgenic is the result of more than a year of dedicated development and thousands of individual microinjections,” said COO Jon Rice.  “We used a completely different approach in designing this new line to solving the challenge of commercially scalable spider silk.  This different approach is perhaps most significant because it offers the possibility to create a super hybrid by merging it with Dragon Silk and other strains.”

“Even as we ramp up the production of Dragon Silk^TM to fulfil our government contract and supply product for industry, we are inventing the next generation of materials to penetrate new markets,” said Company Founder and CEO Kim Thompson.  “This laboratory breakthrough, so close on the heels of the launching of our production facility, emphasizes our lead in this burgeoning field,” continued Thompson.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -October 11, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has reached peak planned capacity at its new Indiana production facility ahead of schedule.   To support the rapid increase in throughput, the Company has hired and is training additional full time workers.  The Company expects to maintain this level of silk production through the fourth quarter of 2016.  The Company has started reviewing plans for possible capacity expansion in light of the successful factory launch and demand from industry.

“The last 30 days have been a buzz of activity at our new plant,” said COO Jon Rice.  “In this short period of time our team has already identified and implemented a number of process and equipment efficiency improvements, which further reinforce our position as the industry leader in spider silk technologies.”

The Company is now conducting a complete assessment of the production facility’s throughput to prepare for the delivery of Dragon Silk^TM to industry customers following the Company’s completion of the first phase of its US Army contract.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs begins Spider Silk production with first batch totaling more than 40,000 silkworms

ANN ARBOR, Mich., -October 3, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)
(“Company”), the leading developer of spider silk based fibers, today announced that the Company has successfully launched production at its new Indiana production facility with the hatching of more than 40,000 silkworms.  With this beginning, the Company is on schedule to produce all of the recombinant spider silk necessary to fulfill its contract with the US Government on time and on budget.  The Company has a large inventory of silkworm eggs ready to hatch and, over the coming weeks, plans to ramp up the hatch rate.  The Company expects the need to hire and train additional staff to keep up with the expanding production volumes.

“Bringing this facility online is a major milestone for Kraig Labs and a significant step forward for spider silk manufacturing”, said COO Jon Rice. “These first 40,000 silkworms are just the beginning of our aggressive plans to scale domestic production.  With this facility, we now have the capability to rapidly respond to the numerous request we receive for our record setting Dragon Silk^TM.  I would like to congratulate our team, whom have been working tirelessly to meet our production schedule and to see this goal realized.”

Over the coming months the Company will be increasing the throughput of this facility and preparing for an expanded U.S. operation which will include the planting of thousands of mulberry trees.

In addition to its new domestic plant, the Company continues to make progress toward the establishment of two separate international production facilities.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

 ANN ARBOR, Mich., -August 31, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has begun the process to open a new production and research center in addition to its new domestic facility and its prospective operations in Vietnam.  This new location is being planned to work in collaboration with the Company’s ongoing production expansion in the United States and prospective production in Vietnam.  To accelerate the process of establishing the new facility, the Company has signed a contract with a team of biotechnology regulation experts with a proven track record of successfully introducing new biotechnologies.

“We are excited to begin this new relationship.  This move to create a third prospective production location has been a consistent element of our long term growth plan for spider silk technologies.  After a thorough assessment of potential locations and collaborators, I believe we have found the ideal location and partners for our planned third production facility,” said COO Jon Rice.  “The regional expertise in silk production and the appetite for ground breaking technology makes this a perfect complement to our plans in Vietnam and our new facility in Indiana.”

The Company’s announcement of its planned overseas expansion follows closely on the heels of the Company’s announcement that it has completed the build out of its new production facility in Indiana.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Kraig Labs signs contract for delivery of 2,000 mulberry trees

ANN ARBOR, Mich., -August 16, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has signed a contract for the delivery of 2,000 mulberry trees.  With the purchase of these trees, the Company will be able to significantly expand its US production of spider silk fibers including both Dragon Silk™ and Monster Silk®.  The Company is currently preparing for the planting of these first two thousand trees and is actively assessing its requirements for additional trees.

Mulberry leaves are an important dietary requirement for the Company’s proprietary transgenic silkworms which spin recombinant spider silk.   The planting of these trees is seen by the Company as the next step in expanding US production.

“The purchase of these trees is an important part of our plans to diversify our production both in the US and overseas. These trees will provide a sustainable, low cost, domestic input source for our US based silk production,” said COO Jon Rice.  “In addition to decreasing our costs and ensuring a stable food supply for our transgenic silkworms, testing in the laboratory has demonstrated that our silkworms produce better silk when fed fresh mulberry.”

The Company plans to use its US based production operations as an agile responsive capacity for domestic orders and as a testbed for future market developments.  This facility will work in parallel with the Company’s planned international high capacity operations.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com